학술논문

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain
Document Type
Article
Source
In: Clinical and Translational Oncology. (Clinical and Translational Oncology, 1 June 2018, 20(6):753-760)
Subject
Language
English
ISSN
16993055
1699048X